Andrew Elliott
Andrew Elliott publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers and Prostate Cancer Treatment and Research.
- World rank
- #603,891 of 7,710,434 ranked researchers
- Rank in United States
- #207,001 of 1,627,098
- Works
- 607
- Citations
- 1.4k
- Citations per work
- 2.3
What does Andrew Elliott research?
Andrew Elliott's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (24%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences32253.0%
- Medicine32253.0%
- Life Sciences14323.6%
- Everything else14223.4%
- 1Oncology23% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Molecular Biology13% of their works
- 4Cancer Research10% of their works
- 5Surgery6% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
Which keywords describe Andrew Elliott's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Tumor Microenvironment, Chemotherapy, Genomic Profiling, Biomarkers, Immunotherapy and Cancer Genomics.
- KRAS Mutations
- Soft Tissue Sarcoma
- Small-Cell Lung Cancer
- Ferroptosis
- EGFR Mutations
- Prostate Cancer
- Prognostic Factors
- Immune Checkpoint Blockade
- Cancer Genomics
- Biomarkers
- Chemotherapy
- Clinical Trials
- Targeted Therapy
- Tumor Microenvironment
- Genomic Profiling
- Immunotherapy
- Mutational Signatures
- PD-1 and PD-L1
- Androgen Receptor
- ALK Inhibitors
- Cancer
- Genomic Profiles
- Osteosarcoma
- Cetuximab
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Targeted Therapy933 topics
- Clinical Trials743 topics
- Tumor Microenvironment662 topics
- Chemotherapy553 topics
- Genomic Profiling532 topics
- Biomarkers482 topics
- Immunotherapy482 topics
- Cancer Genomics461 topic
- Mutational Signatures461 topic
- Immune Checkpoint Blockade441 topic
- PD-1 and PD-L1441 topic
- Prognostic Factors392 topics
- Androgen Receptor271 topic
- Prostate Cancer271 topic
- ALK Inhibitors261 topic
- EGFR Mutations261 topic
- Cancer221 topic
- Ferroptosis221 topic
- Genomic Profiles211 topic
- Small-Cell Lung Cancer211 topic
- Osteosarcoma181 topic
- Soft Tissue Sarcoma181 topic
- Cetuximab161 topic
- KRAS Mutations161 topic
Where does Andrew Elliott work?
Andrew Elliott's main affiliation in the publication record is Caris Life Sciences (United States), United States.
How many publications and citations does Andrew Elliott have?
OpenAlex counts 607 works and 1,410 citations for Andrew Elliott, an h-index of 20, ranking #603,891 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Andrew Elliott
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrew Elliott. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.